According to Digitimes, the current Apple Watch models are sold better than expectations – sales exceed forecasts by about 10%. Next year, the company plans to present the Apple Watch Series 11 and Watch Ultra 3 with noticeable improvements.
According to industry analysts, the new watch will receive updated iron, software and design. One of the main novelties will be the monitoring of blood pressure and, possibly, monitoring of glucose levels. The last function is still in question due to medical requirements, technological difficulties and patent disputes.
It is also reported that in the new models twice as many sensors, which will allow you to rely less on algorithms and use the data more from the sensors themselves. This will most likely improve measurement accuracy, battery work and general performance.
In addition, a large redsign Apple Watch is expected, but the details are not yet disclosed.